Cardinal Health, Inc. (CAH) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
39/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseCAH / S&P 12.70% / 15.20% |
LoseCAH / S&P CAH unavailable / 15.00% |
LoseCAH / S&P CAH unavailable / 50.40% |
| 2026-Q11/3 |
WinCAH / S&P 3.08% / -4.33% |
LoseCAH / S&P CAH unavailable / 11.30% |
LoseCAH / S&P CAH unavailable / 27.70% |
| 2025-Q42/3 |
WinCAH / S&P 31.35% / 2.65% |
WinCAH / S&P 10.08% / 9.00% |
LoseCAH / S&P CAH unavailable / 13.40% |
| 2025-Q30/3 |
LoseCAH / S&P -6.29% / 8.12% |
LoseCAH / S&P 4.39% / 4.61% |
LoseCAH / S&P CAH unavailable / 13.45% |
| 2025-Q21/3 |
WinCAH / S&P 22.39% / 10.94% |
LoseCAH / S&P -1.87% / 4.83% |
LoseCAH / S&P CAH unavailable / 10.63% |
| 2025-Q11/3 |
WinCAH / S&P 16.99% / -4.27% |
LoseCAH / S&P 0.86% / 4.98% |
LoseCAH / S&P CAH unavailable / 10.57% |
| 2024-Q41/3 |
WinCAH / S&P 7.50% / 2.41% |
LoseCAH / S&P 2.91% / 5.25% |
LoseCAH / S&P CAH unavailable / 6.15% |
| 2024-Q32/3 |
WinCAH / S&P 12.99% / 5.89% |
WinCAH / S&P 6.87% / 5.89% |
LoseCAH / S&P CAH unavailable / 6.11% |
| 2024-Q21/3 |
LoseCAH / S&P -12.14% / 4.28% |
WinCAH / S&P 10.66% / 5.38% |
LoseCAH / S&P CAH unavailable / 5.12% |
| 2024-Q12/3 |
WinCAH / S&P 11.51% / 10.56% |
WinCAH / S&P 10.95% / 5.71% |
LoseCAH / S&P CAH unavailable / 5.59% |
| 2023-Q42/3 |
WinCAH / S&P 17.36% / 11.69% |
WinCAH / S&P 11.93% / 6.81% |
LoseCAH / S&P CAH unavailable / 7.78% |
| 2023-Q31/3 |
LoseCAH / S&P -8.19% / -3.27% |
WinCAH / S&P 12.34% / 7.52% |
LoseCAH / S&P CAH unavailable / -5.03% |
| 2023-Q22/3 |
WinCAH / S&P 25.93% / 8.74% |
WinCAH / S&P 13.04% / 9.50% |
LoseCAH / S&P CAH unavailable / -8.57% |
| 2023-Q11/3 |
LoseCAH / S&P -1.13% / 7.50% |
WinCAH / S&P 12.31% / 10.77% |
LoseCAH / S&P CAH unavailable / -15.69% |
| 2022-Q42/3 |
WinCAH / S&P 16.02% / 7.56% |
WinCAH / S&P 12.66% / 11.88% |
LoseCAH / S&P CAH unavailable / -17.99% |
| 2022-Q31/3 |
WinCAH / S&P 28.51% / -4.88% |
LoseCAH / S&P 11.71% / 13.47% |
LoseCAH / S&P CAH unavailable / -1.41% |
| 2022-Q21/3 |
WinCAH / S&P -6.95% / -16.10% |
LoseCAH / S&P 11.61% / 13.71% |
LoseCAH / S&P CAH unavailable / 11.04% |
| 2022-Q11/3 |
WinCAH / S&P 11.06% / -4.60% |
LoseCAH / S&P 12.95% / 15.97% |
LoseCAH / S&P CAH unavailable / 42.23% |
| 2021-Q40/3 |
LoseCAH / S&P 5.09% / 11.03% |
LoseCAH / S&P 9.48% / 15.00% |
LoseCAH / S&P CAH unavailable / 96.40% |
| 2021-Q30/3 |
LoseCAH / S&P -12.53% / 0.58% |
LoseCAH / S&P 8.23% / 10.77% |
LoseCAH / S&P CAH unavailable / 69.42% |
| 2021-Q20/3 |
LoseCAH / S&P -5.21% / 8.55% |
LoseCAH / S&P 6.24% / 6.58% |
LoseCAH / S&P CAH unavailable / 51.81% |
| 2021-Q12/3 |
WinCAH / S&P 14.32% / 6.17% |
WinCAH / S&P 1.94% / -1.06% |
LoseCAH / S&P CAH unavailable / 7.39% |
| 2020-Q42/3 |
WinCAH / S&P 15.12% / 12.15% |
WinCAH / S&P 4.54% / -3.72% |
LoseCAH / S&P CAH unavailable / -33.42% |
| 2020-Q31/3 |
LoseCAH / S&P -9.10% / 8.93% |
WinCAH / S&P 4.73% / -2.04% |
LoseCAH / S&P CAH unavailable / -27.10% |
| 2020-Q21/3 |
LoseCAH / S&P 9.89% / 20.54% |
WinCAH / S&P 5.08% / -0.46% |
LoseCAH / S&P CAH unavailable / -27.11% |
| 2020-Q12/3 |
WinCAH / S&P -4.27% / -19.60% |
WinCAH / S&P 7.01% / 3.47% |
LoseCAH / S&P CAH unavailable / -14.75% |
| 2019-Q41/3 |
LoseCAH / S&P 8.21% / 9.07% |
WinCAH / S&P 5.44% / 5.36% |
LoseCAH / S&P CAH unavailable / 2.99% |
| 2019-Q31/3 |
LoseCAH / S&P 1.21% / 1.70% |
WinCAH / S&P 5.94% / 5.02% |
LoseCAH / S&P CAH unavailable / 0.21% |
| 2019-Q20/3 |
LoseCAH / S&P -1.16% / 4.30% |
LoseCAH / S&P 6.38% / 6.64% |
LoseCAH / S&P CAH unavailable / 8.65% |
| 2019-Q10/3 |
LoseCAH / S&P 9.04% / 13.65% |
LoseCAH / S&P 6.77% / 8.12% |
LoseCAH / S&P CAH unavailable / 14.29% |
| 2018-Q40/3 |
LoseCAH / S&P -16.52% / -13.52% |
LoseCAH / S&P 7.03% / 9.05% |
LoseCAH / S&P CAH unavailable / 18.23% |
| 2018-Q31/3 |
WinCAH / S&P 11.57% / 7.71% |
LoseCAH / S&P 6.74% / 10.21% |
LoseCAH / S&P CAH unavailable / 19.06% |
| 2018-Q20/3 |
LoseCAH / S&P -21.35% / 3.43% |
LoseCAH / S&P 5.26% / 9.03% |
LoseCAH / S&P CAH unavailable / 14.46% |
| 2018-Q11/3 |
WinCAH / S&P 3.06% / -0.76% |
LoseCAH / S&P 4.70% / 7.68% |
LoseCAH / S&P CAH unavailable / 12.46% |
| 2017-Q40/3 |
LoseCAH / S&P -7.76% / 6.64% |
LoseCAH / S&P 4.23% / 7.03% |
LoseCAH / S&P CAH unavailable / 13.82% |
| 2017-Q30/3 |
LoseCAH / S&P -13.52% / 4.48% |
LoseCAH / S&P 4.02% / 5.68% |
LoseCAH / S&P CAH unavailable / 17.57% |
| 2017-Q21/3 |
LoseCAH / S&P -3.89% / 3.09% |
WinCAH / S&P 6.94% / 4.83% |
LoseCAH / S&P CAH unavailable / 17.74% |
| 2017-Q12/3 |
WinCAH / S&P 13.93% / 6.07% |
WinCAH / S&P 9.08% / 3.67% |
LoseCAH / S&P CAH unavailable / 13.32% |
| 2016-Q41/3 |
LoseCAH / S&P -6.80% / 3.82% |
WinCAH / S&P 13.18% / 2.09% |
LoseCAH / S&P CAH unavailable / 7.05% |
| 2016-Q31/3 |
LoseCAH / S&P 0.18% / 3.85% |
WinCAH / S&P 17.85% / 0.20% |
LoseCAH / S&P CAH unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CAH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 59.68% | 20.78% |
| Annualized return | 59.68% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CAH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 400.36% | 83.14% |
| Annualized return | 37.99% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CAH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 289.76% | 319.30% |
| Annualized return | 14.57% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |